790
A. Arnone et al. / Tetrahedron 65 (2009) 786–791
Selected compounds were tested for their cytotoxicity against
non-small cell lung tumour cell line H460, and showed modest
activity. [IC50 M): for 2: 35.7; for 3 >100 and 4: 56].
4.2.2. Synthesis of compound (9) from acremine A (1)
Acremine A (50 mg) was dissolved in dry CH2Cl2 (5 mL) and
treated with m-CPBA (60 mg) for 3 h at rt; the solution was washed
with a solution of NaHCO3, dried and evaporated. The residue was
purified on silica gel (plates 1 mm) with CH2Cl2–MeOH (9:1) as
eluant to obtain 35 mg of the epoxide 9 as an oil and 1.5 mg of
acremine H; ESIMS m/z 265 (MþNa)þ. The 1H and 13C NMR data are
listed on Tables 1 and 2. NOEs (acetone-d6þD2O): {H-2} enhanced
H-10 (0.5%) and H-20 (1.5%), {H-4} enhanced H-5a (3%), H-10 (2.5%),
H-20 (0.5%) and H3-100(1%), {H-10} enhanced H-4 (2%), H-20 (0.5%),
H3-40 (0.5%) and H3-50 (1%), {H-20} enhanced H-2 (2%), H-10 (0.5%),
H3-40 (1%) and H3-50 (1%), {H3-40} enhanced H-10 (1.5%) and H-20
(4.5%), {H3-50} enhanced H-10 (3%) and H-20 (4.5%), {H3-100} en-
hanced H-4 (5%) and H-5a (2.5%).
(
m
3. Conclusion
We have established the structure and stereochemistry of
a further group of acremines (H–N), produced by a strain of
A. byssoides on a culture medium composed by malt extract–
peptone and glucose agar. The oxygenation pattern of these
compounds may suggest that they are formed by bioconversion
of the main metabolite acremine A (1) first to the epoxide 3 and
subsequently to compounds 4, 5a and 7 by the monooxygenase
enzymes of the fungus, grown in particular conditions (MPGA
cultures). It is well known that these enzymes are able to acti-
vate molecular oxygen in order to transfer it to an organic
compound.9
4.2.3. Acremine I (4)
CIMS, m/z 241 (MH)þ (100%), 223 (MHꢁ18)þ (78) and 183
(65); HREIMS, m/z 240.0972 (calcd for C12H16O5 240.0997). The
1H and 13C NMR data are listed in Tables 1 and 2. NOEs
(CDCl3þD2O): {H-2} enhanced H-10 (4.5%) and H-20 (2%), {H-4}
enhanced H-5 (7.5%), H-10 (4%) and H-20 (2.5%), {H-5} enhanced
H-4 (5.5%) and H3-100 (1%), {H-10} enhanced H-2 (5.5%), H-4
(3.5%) and H-20 (1%), {H-20} enhanced H-2 (3.5%), H-10 (2.5%),
H3-40 (1%) and H3-50 (1%), {H3-40} enhanced H-10 (3%) and H-20
(6%), {H3-50} enhanced H-4 (1%), H-10 (3.5%) and H-20 (5%), {H3-
100} enhanced H-5 (7%).
4. Experimental
4.1. General
Flash column chromatography was performed with Merck
silica gel (0.040–0.63 mm); thin and preparative layer chroma-
tography (TLC and PLC) were performed on precoated Merck
silica gel 60 F254 plates. The IR spectra were measured on a Per-
kin–Elmer 177 spectrophotometer. MS spectra were recorded
4.2.4. Acremine L (5a)
HREIMS, m/z 242.1136 (calcd for C12H18O5 242.1154). The 1H and
13C NMR data are listed in Tables 1 and 2.
with
a Bruker Esquire 3000 Plus instrument, HRMS with
a Bruker APEX-QZT ICR. The NMR spectra were recorded with
a Bruker AMX-600 spectrometer, at 600.13 MHz for 1H and
150.92 MHz for 13C.
4.2.5. Acetylation of compound 5a
Compound 5a (30 mg) was dissolved in dry pyridine (0.2 mL)
and treated with Ac2O (0.5 mL) overnight at 0 ꢀC. Standard work-up
followed by PLC on silica gel in hexane–EtOAc (2:1) gave mainly the
diacetate 5d (18 mg) as a solid, mp 120–125 ꢀC; ESIMS, m/z 349
(MþNa)þ and 675 (2MþNa)þ and the monoacetates 5b and 5c in
the ratio 3:1. Compound 5b. Rf (hexane–ethyl acetate 2:1) 0.4; 1H
4.2. Culture of A. byssoides, extraction and isolation
of acremines H–N
The fungal strain A20 was isolated in pure culture from grape-
vine leaves infected by P. viticola and identified as A. byssoides, by
conventional taxonomy.1 For chemical investigations, the fungus
was grown in batches of 40 Roux flasks containing 100 mL MPGA
(malt extract–peptone–glucose agar, 20, 2, 20 and 15 g Lꢁ1). After
two-week-growth period at 24 ꢀC, the cultures were extracted
twice with EtOAc–MeOH (100:1). The extracts (1.8 g) were dried on
Na2SO4, evaporated to dryness and chromatographed on a silica gel
flash column eluted with hexane–EtOAc at increasing polarity.
Collected fractions were further purified by means of PLC with
CH2Cl2–MeOH 9:1 to give the pure metabolites in order of de-
creasing Rf value: acremine N (8) (75 mg, Rf 0.5), acremine B (2)
(60 mg), acremine I (4) (140 mg, Rf 0.4), acremine C (6) (65 mg),
acremine H (3) (186 mg, Rf 0.3), acremine L (5a) (220 mg, Rf 0.3) and
acremine M (7) (15 mg, Rf 0.2).
NMR (acetone-d6) d: 1.17 (3H, s, Me), 1.24 (3H, s, Me), 1.19 (3H, d, J
6.8 Hz, MeCH), 2.16 (3H, s, OCOMe), 2.51 (1H, dq, J 6.8, 11.1 Hz,
CHMe), 2.84 (1H, d, J 2.1 Hz, CHO), 3.43 (1H, s, OH), 3.57 (1H, ddd, J
0.8, 1.0, 2.1 Hz, CHO), 3.77 (1H, ddd, J 5.5, 8.2, 11.1 Hz, CHOH), 4.83
(1H, d, J 5.5 Hz, OH), 5.80 (1H, ddd, J 0.8, 2.3, 8.2 Hz, CHOCO), 5.92
(1H, dd, J 1.0, 2.3 Hz, CH]C).
4.2.6. Compound 5c
Rf (hexane–ethyl acetate 2:1) 0.3; 1H NMR (acetone-d6)
d: 1.06
(3H, d, J 6.8 Hz, MeCH), 1.22 (3H, s, Me), 1.26 (3H, s, Me), 2.09
(3H, s, OCOMe), 2.56 (1H, dq, J 6.8, 11.2 Hz, CHMe), 2.88 (1H, d, J
2.1 Hz, CHO), 3.51 (1H, s, OH), 3.98 (1H, ddd, J 0.8, 1.1, 2.1 Hz,
CHO), 4.65 (1H, dddd, J 0.8, 2.2, 6.8, 8.3 Hz, CHOH), 5.05 (1H, dd, J
8.3 11.2 Hz, CHOCO), 5.13 (1H, d, J 6.8 Hz, OH), 5.88 (1H, dd, J 1.1,
2.2 Hz, CH]C).
4.2.1. Acremine H (3)
UV: lmax 220 and 280 nm (3 1875 and 17.620); IR: nmax (KBr)
1685 cmꢁ1, conj. CO group; CIMS, m/z 243 (MH)þ (22%), 227
(100) and 209 (30). (Found: C, 59.6; H, 7.6; C12H18O5 requires C,
59.49; H, 7.48.) The 1H and 13C NMR data are listed in Tables 1
and 2. NOEs (acetone-d6þD2O): {H-2} enhanced H-10 (2%) and H-
20 (2.5%), {H-4} enhanced H-5a (4.5%), H-5b (0.5%), H-10 (1.5%),
H-20 (1.5%) and H3-100 (1%), {5a} enhanced H-4 (3%), H-5b (7%)
and H3-100 (1%), {H-5b} enhanced H-4 (0.5%), H-5a (9%) and H3-
100 (0.5%), {H-10} enhanced H-2 (2.5%), H-4 (1%), H-20 (1%), H3-40
(0.5%) and H3-50 (0.5%), {H-20} enhanced H-2 (3%), H-4 (1%), H-10
(1%), H3-40 (0.5%) and H3-50 (0.5%), {H3-40 and H3-50} enhanced
H-10 (8%) and H-20 (11), {H3-100} enhanced H-4 (8%), H-5a (3%)
and H-5b (0.5%).
4.2.7. Compound 5d
Rf (hexane–ethyl acetate 2:1) 0.6; 1H NMR (acetone-d6)
d: 1.10
(3H, d, J 6.8 Hz, MeCH), 1.17 (3H, s, Me), 1.24 (3H, s, Me), 2.05 (3H, s,
OCOMe), 2.12 (3H, s, OCOMe), 2.76 (1H, dq, J 6.8,11.1 Hz, CHMe), 2.87
(1H, d, J 2.2 Hz, CHO), 3.49 (1H, s, OH), 3.61 (1H, ddd, J 0.7,1.2, 2.2 Hz,
CHO), 5.22 (1H, dd, J 8.2, 11.1 Hz, CHOCO), 5.98 (1H, ddd, J 0.7, 2.2,
8.2 Hz, CHOCO), 6.01 (1H, dd, J 1.2, 2.2 Hz, H-2).
4.2.8. Acremine M (7)
Oil; UV: lmax 204, 245 and 290 sh (3 9720, 10,000 and 6350); IR:
nmax 1682 cmꢁ1, conj. CO group; EIMS, m/z 257 (MH)þ (10%), 239
(40), 221 (18) and 59 (100); HREIMS: 242.1146 (calcd for C12H18O5